Citius Oncology, Inc. (CTOR)

NASDAQ: CTOR · Real-Time Price · USD

1.090

-0.040 (-3.54%)

At close: Jan 9, 2026, 4:00 PM EST

1.070

-0.020 (-1.83%)

After-hours: Jan 9, 2026, 6:26 PM EST

Citius Oncology Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022
Selling, General & Admin	17.1	15.65	7.88	2.86
Research & Development	6.42	4.93	4.24	6.86
Operating Expenses	23.52	20.57	12.12	9.71
Operating Income	-23.52	-20.57	-12.12	-9.71
Interest Expense	-0.22	-	-	-
Interest & Investment Income	0.04	-	-	-
Pretax Income	-23.7	-20.57	-12.12	-9.71
Income Tax Expense	1.06	0.58	0.58	1.15
Net Income	-24.76	-21.15	-12.7	-10.87
Net Income to Common	-24.76	-21.15	-12.7	-10.87
Shares Outstanding (Basic)	73	68	68	34
Shares Outstanding (Diluted)	73	68	68	34
Shares Change (YoY)	7.66%	0.82%	100.00%	-
EPS (Basic)	-0.34	-0.31	-0.19	-0.32
EPS (Diluted)	-0.34	-0.31	-0.19	-0.32
EBIT	-23.52	-20.57	-12.12	-9.71

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q